Biosortia Microbiomics
Directly obtaining the drug-like small molecules of microbiomes for therapeutic discovery & massive ML, AI, and genomic datasets speeding clinical approvals.
- Stage Full Product Ready
- Industry Biotechnology
- Location Dublin, OH, USA
- Currency USD
- Founded January 2011
- Employees 6
- Incorporation Type C-corp
- Website biosortia.com
Company Summary
Biosortia Microbiomics provides small molecules and datasets from our deep access to unculturable microbes in microbiomes, a valuable proven source for future therapeutics. Our unique direct access to previously inaccessible microbial small molecules and extensive datasets accelerate discovery in critical life science areas, including new opportunities with next-generation drugs, agrochemicals, longevity, sustainability, advanced energy, & more.
Team
-
CEO, Founder, Inventor
Engineering, technologies, processing, accelerating growth, partnerships, relationship building, grant management, rapid growth, complex project management, driving revenue, team leadership, and thought leadership.
Other: Serial Entrepreneur
Five-time INC 500 CEO with the company listed in the INC Hall of Fame,
National US Business Person of the Year in 1998, awarded by SBA & Al Gore, Significant non-dilutive funding from ARPA-E, DARPA, USAF-RL
Starting a startup?
Join the world's largest startup network for guidance, tools, and fundraising opportunities.